Is the Options Market Predicting a Spike in SSB Stock? — Neutral
SSB Zacks Investment Research — November 17, 2025Investors need to pay close attention to SouthState Bank stock based on the movements in the options market lately.
3 Reasons Growth Investors Will Love Comfort Systems (FIX) — Positive
FIX Zacks Investment Research — November 17, 2025Comfort Systems (FIX) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Here is Why Growth Investors Should Buy OppFi (OPFI) Now — Positive
OPFI Zacks Investment Research — November 17, 2025OppFi (OPFI) possesses solid growth attributes, which could help it handily outperform the market.
Here is Why Growth Investors Should Buy Northrim (NRIM) Now — Positive
NRIM Zacks Investment Research — November 17, 2025Northrim (NRIM) possesses solid growth attributes, which could help it handily outperform the market.
3 Reasons Growth Investors Will Love HCI Group (HCI) — Positive
HCI Zacks Investment Research — November 17, 2025HCI Group (HCI) possesses solid growth attributes, which could help it handily outperform the market.
3 Reasons Why Growth Investors Shouldn't Overlook Kaiser (KALU) — Positive
KALU Zacks Investment Research — November 17, 2025Kaiser (KALU) could produce exceptional returns because of its solid growth attributes.
Is Amazon (AMZN) a Solid Growth Stock? 3 Reasons to Think "Yes" — Positive
AMZN Zacks Investment Research — November 17, 2025Amazon (AMZN) possesses solid growth attributes, which could help it handily outperform the market.
Alphabet (GOOG) is an Incredible Growth Stock: 3 Reasons Why — Positive
GOOG GOOGL Zacks Investment Research — November 17, 2025Alphabet (GOOG) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Looking for a Growth Stock? 3 Reasons Why WisdomTree, Inc. (WT) is a Solid Choice — Positive
WT Zacks Investment Research — November 17, 2025WisdomTree, Inc. (WT) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Here is Why Growth Investors Should Buy Alphabet (GOOGL) Now — Positive
GOOG GOOGL Zacks Investment Research — November 17, 2025Alphabet (GOOGL) possesses solid growth attributes, which could help it handily outperform the market.
Will Nvidia Stock Rally After Its Q3 Earnings Report? — Positive
NVDA Investors Business Daily — November 17, 2025Analysts are wondering if Nvidia CEO Jensen Huang can say anything that will drive Nvidia stock higher after its Q3 report.
Zymeworks Surges On Positive Ziihera Phase 3 Data: Expanding First-Line GEA Opportunity — Positive
ZYME Seeking Alpha — November 17, 2025Zymeworks Inc. (ZYME) surged after positive Phase 3 results for Ziihera in first-line HER2-positive gastroesophageal adenocarcinoma, expanding its FDA-approved indications. ZYME's partnership-driven model, strong cash position, and milestone revenues limit capital risk and provide a projected runway into 2H27. The positive Ziihera data supports regulatory submission in 2026, with key catalysts including full data presentation and sBLA filing, and potential label expansion.
CarMax, Inc. (KMX) Investors: January 2, 2026 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP — Neutral
KMX PRNewsWire — November 17, 2025RADNOR, Pa. , Nov. 17, 2025 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that an amended securities class action lawsuit has been filed against CarMax, Inc. ("CarMax") (NYSE: KMX) which expands the class period to include those who purchased or otherwise acquired CarMax securities between June 20, 2025, and November 5, 2025, inclusive (the "Class Period").
CYTK DEADLINE: ROSEN, GLOBAL INVESTOR RIGHTS COUNSEL, Encourages Cytokinetics, Inc. Investors to Secure Counsel Before Important November 17 Deadline in Securities Class Action - CYTK — Neutral
CYTK Newsfile Corp — November 17, 2025New York, New York--(Newsfile Corp. - November 17, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Cytokinetics, Inc. (NASDAQ: CYTK) between December 27, 2023 and May 6, 2025, both dates inclusive (the "Class Period"), of the important November 17, 2025 lead plaintiff deadline. SO WHAT: If you purchased Cytokinetics common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
U.S. Investigators Probe Exec Facing Fraud Allegations From BlackRock's HPS — Negative
BLK WSJ — November 17, 2025Federal officials have opened a criminal investigation into Bankim Brahmbhatt, who was sued by HPS and other lenders earlier this year.
Update On The Chinese Large-Cap FXI ETF: Risky But Undervalued — Positive
FXI Seeking Alpha — November 17, 2025iShares China Large-Cap ETF offers significant upside potential as Chinese stocks remain undervalued compared to global peers. FXI has shown a strong bullish trend since early 2024, with technical resistance at $42 and upside targets at $54.52 and $73.19. FXI boasts high liquidity and momentum grades, but investors should be mindful of U.S.-China tensions and FXI's expense ratio.
Goldman Sachs sees oil prices falling through 2026 on supply surge — Negative
BNO DBO GUSH IEO OIH OIL PXJ UCO USO XOP Reuters — November 17, 2025Oil prices are expected to decline through 2026, Goldman Sachs said on Monday, citing a production surge that will keep the market in a large surplus of around 2 million barrels per day.
Ecolab Launches Integrated Cooling Platform to Support AI Data Centers — Positive
ECL Zacks Investment Research — November 17, 2025ECL's new Cooling as a Service platform targets soaring AI data center demand with integrated site-to-chip efficiency upgrades.
Bit Digital draws continued analyst support as it expands Ethereum treasury — Positive
BTBT Proactive Investors — November 17, 2025Analysts at Noble Capital Markets have repeated their ‘Outperform' rating on Bit Digital Inc (NASDAQ:BTBT) following its latest quarterly results, which marked the company's first full reporting period as an Ethereum (ETH)-focused treasury and staking operation. Their price target of $5.50 implies upside of about 140% from current levels.
AmEx Flies 20.4% YTD: Should Investors Tap in Before it Boards? — Positive
AXP Zacks Investment Research — November 17, 2025AmEx's 20.4% YTD surge, strong valuation edge and resilient premium spenders raise the question of where the card giant heads next.
